HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities

Gynecologic Oncology

Volumn 100, Issue 3, 2006, Pages 469-478

  Santin, Alessandro D ^a   Bellone, Stefania ^a   Palmieri, Michela ^a   Ravaggi, Antonella ^b   Romani, Chiara ^b   Tassi, Renata ^b   Roman, Juan J ^a   Burnett, Alexander ^a   Pecorelli, Sergio ^b   Cannon, Martin J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cervical cancer; CTLs; Dendritic cells; E7; HPV

Indexed keywords

CANCER VACCINE; DENDRITIC CELL VACCINE; GAMMA INTERFERON; PARACETAMOL; PROTEIN E7; RECOMBINANT INTERLEUKIN 2;

ADULT; ANAPHYLACTIC SHOCK; ARTICLE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; ERYTHEMA; FEMALE; FLU LIKE SYNDROME; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IRRADIATION; LIVER TOXICITY; LOW DRUG DOSE; LYMPHADENOPATHY; METASTASIS; MONOCYTE; NEPHROTOXICITY; PRIORITY JOURNAL; PRURITUS; RECURRENT CANCER; SEROLOGY; SKIN INDURATION; SWELLING; SYSTEMIC DISEASE; TUMOR GROWTH; UTERINE CERVIX CANCER; VACCINATION; VACCINATION REACTION; VIRUS RECOMBINANT;

ADULT; ANTIGENS, VIRAL; B-LYMPHOCYTES; CANCER VACCINES; DENDRITIC CELLS; DNA-BINDING PROTEINS; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; NEOPLASM RECURRENCE, LOCAL; ONCOGENE PROTEINS, VIRAL; T-LYMPHOCYTES; UTERINE CERVICAL NEOPLASMS;

EID: 32644462764     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.09.040     Document Type: Article

References (31)

1. P.J. DiSaia, and W.T. Creasman Cervical cancer P.J. DiSaia W.T. Creasman Clinical gynecologic oncology 1997 Mosby-Year Book, Inc. St. Louis 1 106
2. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J. Pathol. 189 1999 12 19
3. F.X. Bosch, M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, and J. Peto Prevalence of human papillomavirus in cervical cancer: a worldwide perspective J. Nat. Cancer Inst. 87 1995 796 802
4. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
5. G. Schuler, and R.M. Steinman Dendritic cells as adjuvants for immune-mediated resistance to tumors J. Exp. Med. 186 1996 1183 1187
6. + lymphocytes by E7 pulsed autologous dendritic cells in patients with HPV16 and 18 positive cervical cancer J. Virol. 73 1999 5402 5410
7. M.V. Dhodapkar, R.M. Steinman, M. Sapp, H. Desai, C. Fossella, and J. Krasovsky Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells J. Clin. Invest. 104 1999 173 180
8. M.V. Dhodapkar, J. Krasovsky, R.M. Steinman, and N. Bhardwaj Mature dendritic cells boost functionally superior CD8+ T-cell responses in human without foreign helper epitopes J. Clin. Invest. 105 2000 R9 R14
9. F.J. Hsu, C. Benike, F. Fagnoni, T.M. Liles, D. Czerwinski, and B. Taidi Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells Nat. Med. 2 1996 52 58
10. F.O. Nestle, S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, and R. Dummer Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nat. Med. 4 1998 328 332
11. B. Thurner, I. Haendle, C. Roder, D. Dieckmann, P. Keikavoussi, and H. Jonuleit Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma J. Exp. Med. 190 1999 1669 1678
12. A.D. Santin, P.L. Hermonat, A. Ravaggi, S. Bellone, J.J. Roman, and S. Jayaprabhu Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells Clin. Cancer Res. 7 2001 804s 810s
13. P. Sehr, K. Zumbach, and M. Pawlita A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology J. Immunol. Methods 253 2001 153 162
14. M. Muller, R.P. Viscidi, Y. Sun, E. Guerrero, P.M. Hill, and F. Shah Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer Virology 187 1992 508 514
15. A.D. Santin, P.L. Hermonat, A. Ravaggi, M. Chiriva-Internati, M.J. Cannon, and J.C. Hiserodt Expression of surface antigens during the differentiation of human dendritic cell versus macrophages from blood monocytes in vitro Immunobiology 200 1999 187 204
16. A.D. Santin, S. Bellone, M. Gokden, M.J. Cannon, and G.P. Parham Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer N. Engl. J. Med. 346 2002 1752 1753
17. M.F. Connor, and P.L. Stern Loss of MHC class-I expression in cervical carcinomas Int. J. Cancer 46 1990 1029 1034
18. W.J. van Driel, M.Y. Thong, C.G.J.M. Hilders, B.J. Trimbos, and G.J. Fleuren Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma Gynecol. Oncol. 62 1996 33 41
19. A. Ferrara, M. Nonn, P. Sehr, C. Schreckenberger, M. Pawlita, and M. Dürst Dendritic cell-based tumor vaccine for cervical cancer: II. Results of a clinical pilot study in 15 individual patients J. Cancer Res. Clin. Oncol. 129 2003 521 530
20. M.L. De Bruijn, D.H. Schuurhuis, M.P. Vierboom, H. Vermeulen, K.A. de Cock, and M.E. Ooms Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells Cancer Res. 58 1998 724 731
21. + T cell help J. Exp. Med. 186 1997 65 70
22. E.A. Walter, P.D. Greenberg, M.J. Gilbert, R.J. Finch, K.S. Watanabe, and E.D. Thomas Recognition of cellular immunity against cytomegalovirus in recipient of allogenic bone marrow by transfer of T-cell clones from donor N. Engl. J. Med. 333 1995 1038 1044
23. M.G. Von Herrath, J. Yokoyama, M.B.A. Dockter Oldstone, and J.L. Whitton CD4 deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge J. Virol. 70 1996 1072 1079
24. A. Lanzavecchia A license to kill Nature 393 1998 413 414
25. S. Guerder, and P. Matzinger A fail-safe mechanism for maintaining self-tolerance J. Exp. Med. 176 1992 553 564
26. + cells after a transient response to antigen Eur. J. Immunol. 23 1993 1963 1967
27. K. Kono, M.E. Ressing, R.M.P. Brandt, J.M. Melief, R.K. Potkul, and B. Andersson Decreased expression of signal-transducing ζ chain in peripheral T cells and natural killer cells in patients with cervical cancer Clin. Cancer Res. 2 1996 1825 1828
28. A.D. Santin, S. Bellone, M. Palmieri, B. Bossini, J.J. Roman, and M.J. Cannon Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix Gynecol. Oncol. 89 2003 271 280
29. A.D. Santin, P.L. Hermonat, A. Ravaggi, S. Bellone, J. Roman, and S. Pecorelli Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix Int. J. Radiat. Oncol. Biol. Phys. 48 2000 997 1006
30. A.D. Santin, S. Bellone, M. Palmieri, B. Bossini, D. Dunn, and J.J. Roman Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10 Int. J. Radiat. Oncol. Biol. Phys. 54 2002 1345 1355
31. A. Fiander, M. Adams, A.S. Evans, A.J. Bennett, and L.K. Borysiewicz Immunocompetent for immunotherapy? A study of the immunocompetence of cervical cancer patients Int. J. Gynecol. Oncol. 5 1995 438 442